Detailed Molecular and Immune Marker Profiling of Archival Prostate Cancer Samples Reveals an Inverse Association between TMPRSS2:ERG Fusion Status and Immune Cell Infiltration
Rao SR. et al, (2020), The Journal of Molecular Diagnostics, 22, 652 - 669
Genomic copy number predicts oesophageal cancer years before transformation
Killcoyne S. et al, (2020)
Inferring structural variant cancer cell fraction.
Cmero M. et al, (2020), Nature communications, 11
Reconstructing evolutionary trajectories of mutation signature activities in cancer using TrackSig.
Rubanova Y. et al, (2020), Nature communications, 11
A community effort to create standards for evaluating tumor subclonal reconstruction
Salcedo A. et al, (2020), Nature Biotechnology, 38, 97 - 107
Genomic evidence supports a clonal diaspora model for metastases of esophageal adenocarcinoma
Noorani A. et al, (2020), Nature Genetics, 52, 74 - 83
Genomic landscape and chronological reconstruction of driver events in multiple myeloma
Maura F. et al, (2019), Nature Communications, 10
Profiling molecular regulators of recurrence in chemorefractory triple-negative breast cancers.
Hancock BA. et al, (2019), Breast Cancer Res, 21
Characterizing Mutational Signatures in Human Cancer Cell Lines Reveals Episodic APOBEC Mutagenesis
Petljak M. et al, (2019), Cell, 176, 1282 - 1294.e20
Author Correction: Landscape of somatic mutations in 560 breast cancer whole-genome sequences.
Nik-Zainal S. et al, (2019), Nature, 566
Author Correction: Pan-cancer analysis of homozygous deletions in primary tumours uncovers rare tumour suppressors.
Cheng J. et al, (2019), Nat Commun, 10
Author Correction: Pan-cancer analysis of homozygous deletions in primary tumours uncovers rare tumour suppressors.
Cheng J. et al, (2018), Nat Commun, 9
Genomic patterns of progression in smoldering multiple myeloma
Bolli N. et al, (2018), Nature Communications, 9
Time series analysis of neoadjuvant chemotherapy and bevacizumab-treated breast carcinomas reveals a systemic shift in genomic aberrations.
Höglander EK. et al, (2018), Genome Med, 10
A unified haplotype-based method for accurate and comprehensive variant calling
Cooke DP. et al, (2018)
Classification and Personalized Prognosis in Myeloproliferative Neoplasms.
Grinfeld J. et al, (2018), N Engl J Med, 379, 1416 - 1430